PCASettings
|
|
1 |
|
|
Albania Argentina Australia Austria Belgium Brazil Bulgaria Chile China Croatia Czech Republic Denmark Egypt Estonia Finland France Georgia Germany Greece Guadeloupe Hungary Iran Ireland Israel Italy Jordan Latvia Lebanon Lithuania Macedonia Mexico Morocco Netherlands New Zealand Philippines Peru Poland Portugal Romania Russia Slovakia South Africa Spain Sweden Switzerland Syria Taiwan Thailand Tunisia Turkey United Arab Emirates United Kingdom U.S.A. Venezuela Zaire |
|
|
|
|
|
Active surveillance Age Biopsy Colostomy Diagnosis DRE Dutasteride Finasteride Gene Over-treatment PCA3 PCA3 Score Progression Prostate cancer specific PSA Test Time Treatment Urination Urinary tract infection Urologist |
|
|
Aktiven Überwachungsstrategie Alter Behandlung Biopsie Colostoma Diagnose DRU Dutasterid Finasterid Gen Harnwegsinfekt PCA3 PCA3-Score Progression Prostatakrebs-spezifisch PSA Test Timing Überbehandlung Urinieren Urologe |
|
|
Âge Biopsie Colostomie Diagnostic Durée Dutastéride Evolution Finastéride Gène Infection urinaire PCA3 PSA Score PCA3 Spécifique du cancer de la prostate Surtraitement Surveillance active Test Toucher rectal Traitement Uriner Urologue |
|
|
Behandeling Biopsie Colostomie Diagnose DRE Dutasteride Finasteride Gen Leeftijd Over-behandeling PCA3 PCA3 Score Progressie Prostaatkanker-specifiek PSA Test Tijd Uitgestelde therapie Urineren Urineweginfectie Uroloog |
Find the answer to all your questions about PCA3 in the frequently asked questions section
Use tools from research institutions developed to predict the risk of prostate cancer